Suppr超能文献

围产期干细胞:一种用于颅面骨组织工程的有前景的细胞资源。

Perinatal stem cells: A promising cell resource for tissue engineering of craniofacial bone.

作者信息

Si Jia-Wen, Wang Xu-Dong, Shen Steve Gf

机构信息

Jia-Wen Si, Xu-Dong Wang, Steve GF Shen, Department of Oral and Craniomaxillofacial Science, Shanghai Ninth People's Hospital College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.

出版信息

World J Stem Cells. 2015 Jan 26;7(1):149-59. doi: 10.4252/wjsc.v7.i1.149.

Abstract

In facing the mounting clinical challenge and suboptimal techniques of craniofacial bone defects resulting from various conditions, such as congenital malformations, osteomyelitis, trauma and tumor resection, the ongoing research of regenerative medicine using stem cells and concurrent advancement in biotechnology have shifted the focus from surgical reconstruction to a novel stem cell-based tissue engineering strategy for customized and functional craniofacial bone regeneration. Given the unique ontogenetical and cell biological properties of perinatal stem cells, emerging evidence has suggested these extraembryonic tissue-derived stem cells to be a promising cell source for extensive use in regenerative medicine and tissue engineering. In this review, we summarize the current achievements and obstacles in stem cell-based craniofacial bone regeneration and subsequently we address the characteristics of various types of perinatal stem cells and their novel application in tissue engineering of craniofacial bone. We propose the promising feasibility and scope of perinatal stem cell-based craniofacial bone tissue engineering for future clinical application.

摘要

面对因先天性畸形、骨髓炎、创伤和肿瘤切除等各种情况导致的颅面骨缺损日益增加的临床挑战以及不尽人意的技术,利用干细胞的再生医学研究不断推进,同时生物技术也不断进步,这已将重点从手术重建转向一种基于干细胞的新型组织工程策略,以实现定制化和功能性颅面骨再生。鉴于围产期干细胞独特的个体发生和细胞生物学特性,新出现的证据表明,这些来自胚外组织的干细胞是再生医学和组织工程广泛应用的一种有前景的细胞来源。在本综述中,我们总结了基于干细胞的颅面骨再生的当前成就和障碍,随后阐述了各种围产期干细胞的特征及其在颅面骨组织工程中的新应用。我们提出了基于围产期干细胞的颅面骨组织工程在未来临床应用中具有前景的可行性和范围。

相似文献

1
Perinatal stem cells: A promising cell resource for tissue engineering of craniofacial bone.
World J Stem Cells. 2015 Jan 26;7(1):149-59. doi: 10.4252/wjsc.v7.i1.149.
2
Cellular Senescence in Craniofacial Tissue Regeneration: Inducers, Biomarkers, and Interventions.
Tissue Eng Part B Rev. 2024 Feb;30(1):128-141. doi: 10.1089/ten.TEB.2023.0136. Epub 2023 Sep 11.
3
Bone marrow-derived mesenchymal stem cells for regenerative medicine in craniofacial region.
Oral Dis. 2006 Nov;12(6):514-22. doi: 10.1111/j.1601-0825.2006.01300.x.
4
Advances of mesenchymal stem cells derived from bone marrow and dental tissue in craniofacial tissue engineering.
Curr Stem Cell Res Ther. 2014 May;9(3):150-61. doi: 10.2174/1574888x09666140213142258.
7
Skeletal Stem Cells-A Paradigm Shift in the Field of Craniofacial Bone Tissue Engineering.
Front Dent Med. 2020 Nov;1. doi: 10.3389/fdmed.2020.596706. Epub 2020 Nov 23.
8
Challenges of Stem-cell-based Craniofacial Regeneration.
Curr Stem Cell Res Ther. 2021;16(6):670-682. doi: 10.2174/1574888X16999210128193910.
9
Stem cells, growth factors and scaffolds in craniofacial regenerative medicine.
Genes Dis. 2016 Mar;3(1):56-71. doi: 10.1016/j.gendis.2015.09.004. Epub 2015 Oct 17.

引用本文的文献

1
Categories, applications, and potential of stem cells in bone regeneration: an overview.
Front Med (Lausanne). 2025 Aug 20;12:1606100. doi: 10.3389/fmed.2025.1606100. eCollection 2025.
3
Effects of TGF-β3 on meniscus repair using human amniotic epithelial cells.
J Orthop Surg Res. 2025 Mar 10;20(1):255. doi: 10.1186/s13018-025-05640-3.
6
Combination of stem cell therapy and acupuncture to treat ischemic stroke: a prospective review.
Stem Cell Res Ther. 2022 Mar 3;13(1):87. doi: 10.1186/s13287-022-02761-y.
7
Stem cells and COVID-19: are the human amniotic cells a new hope for therapies against the SARS-CoV-2 virus?
Stem Cell Res Ther. 2021 Mar 1;12(1):155. doi: 10.1186/s13287-021-02216-w.
8
10
Proliferation and survival of human amniotic epithelial cells during their hepatic differentiation.
PLoS One. 2018 Jan 18;13(1):e0191489. doi: 10.1371/journal.pone.0191489. eCollection 2018.

本文引用的文献

1
Amniotic membrane-derived stem cells: immunomodulatory properties and potential clinical application.
Stem Cells Cloning. 2014 Mar 24;7:53-63. doi: 10.2147/SCCAA.S58696. eCollection 2014.
3
The subtype CD200-positive, chorionic mesenchymal stem cells from the placenta promote regeneration of human hepatocytes.
Biotechnol Lett. 2014 Jun;36(6):1335-41. doi: 10.1007/s10529-014-1468-7. Epub 2014 Feb 23.
4
Umbilical cord and bone marrow mesenchymal stem cell seeding on macroporous calcium phosphate for bone regeneration in rat cranial defects.
Biomaterials. 2013 Dec;34(38):9917-25. doi: 10.1016/j.biomaterials.2013.09.002. Epub 2013 Sep 18.
5
Potential of human fetal chorionic stem cells for the treatment of osteogenesis imperfecta.
Stem Cells Dev. 2014 Feb 1;23(3):262-76. doi: 10.1089/scd.2013.0132. Epub 2013 Oct 16.
9
Engineering bone tissue substitutes from human induced pluripotent stem cells.
Proc Natl Acad Sci U S A. 2013 May 21;110(21):8680-5. doi: 10.1073/pnas.1301190110. Epub 2013 May 7.
10
Technological overview of iPS induction from human adult somatic cells.
Curr Gene Ther. 2013 Apr;13(2):73-92. doi: 10.2174/1566523211313020002.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验